Company / Book Value per Share
Amylyx Pharmaceuticals, Inc. Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.778
FY2025
5-year range
-$22.952 / $48.516
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#139 of 209
Health Care
What the data says
At $2.778, Amylyx Pharmaceuticals, Inc.'s book value per share ranks #139 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $2.778.
Based on SEC 10-K filings.
$2.778 in FY2025 with a 3-year CAGR of -61.5%.
Declined from $6.402 to $2.778 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -61.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#139 of 209 in Health CareTop 67% of 209This company $2.778 Sector average $189.406
▼
-98.5% below sector average
Key checks
Key Insights
- 3-year CAGR of -61.5%, indicating a declining trend.
- In FY2025, book value per share increased 15.7% year-over-year.
- Ranks #139 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.778 | +15.7% |
| FY2024 | $2.401 | -62.5% |
| FY2023 | $6.402 | -86.8% |
| FY2022 | $48.516 | +311.4% |
| FY2021 | -$22.952 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026